Innovision IPO GMP: Key Details and Market Expectations
Innovision IPO Details
Innovision Ltd is gearing up for its initial public offering (IPO), aiming to raise ₹323 crore with a price band set between ₹521 and ₹548 per share. The IPO will be open for bidding from March 10 to March 12, 2026, with an expected allotment date of March 13, 2026, and a listing date on March 17, 2026.
The lot size for the Innovision IPO is 27 shares, making it accessible for a range of investors. However, shares are currently trading at a grey market premium (GMP) of ₹0, indicating a cautious sentiment among potential investors.
Market Insights
Analysts have mixed views on the IPO’s valuation. Swastika Investmart noted that Innovision’s return on net worth (RoNW) of 35.45% is significantly higher than its peers, with the next best at 19%. This performance signals efficient capital use and partially justifies the premium pricing.
Conversely, Avinash Gorakshkar expressed concerns, stating, “The issue looks highly priced as its PE stands around 45 at the end of FY25.” This perspective highlights the potential risks for investors considering the IPO.
Innovision has shown robust growth over the past two years, primarily driven by its expansion in toll plaza management and manpower services. Ventura Securities remarked on this growth trajectory, suggesting it may attract investor interest despite the high valuation.
However, SBI Securities cautioned that the IPO valuations appear to be premium, which could deter some investors. The overall sentiment in the market remains cautious as the IPO date approaches.
Innovision provides a range of services including manpower solutions, toll plaza management, and skill development training across India. This diverse portfolio has positioned the company for growth, but the upcoming IPO will test market appetite for its shares.
As the IPO date nears, observers are keenly watching how the market will respond to Innovision’s offering, particularly in light of the current grey market conditions. Details remain unconfirmed regarding investor interest and potential oversubscription levels.
